The Latest Breaking News from Abbott Laboratories

The S&P 500 Index ($SPX ) (SPY ) today is down -2.38%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -3.29%. June E-mini S&P futures (ESM25 ) are down -2.16%, and June E-mini Nasdaq futures...

Abbott Laboratories is expected to announce its first-quarter results this month, and analysts predict a single-digit growth in the company’s bottom-line figure.

Abbott Laboratories has notably outpaced the Dow Jones Industrial Average over the past year and analysts remain strongly bullish on the stock’s prospects.

Abbott Laboratories has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

The healthcare industry is poised for growth driven by aging populations, technological advancements, and increased healthcare spending. Hence, investors might consider investing in healthcare stocks, such as UnitedHealth Group (UNH), Abbott Laboratories (ABT), and Medtronic (MDT), which address the needs of the aging population. Read more….

The healthcare IT market is driving digital transformation by enhancing efficiency, addressing workforce shortages, and promoting personalized care, making it a promising investment sector. Therefore, strong healthcare IT stocks like Medtronic (MDT), Abbott Laboratories (ABT), and Embecta (EMBC) could be wise additions to your portfolio. Read more.

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

Abbott Laboratories is one of the best dividend stocks to buy today: here's why.

The medtech market is thriving, thanks to the increasing investments and surging demand for enhanced efficiency. Therefore, investors could benefit from these trends by investing in fundamentally solid medical device stocks Becton, Dickinson and Company (BDX), Medtronic (MDT), and Abbott Laboratories (ABT), which are revolutionizing patient care. Keep reading.

The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical technology. Hence, investors might consider investing in healthcare stocks, Eli Lilly (LLY), Thermo Fisher Scientific (TMO), and Abbott Laboratories (ABT) for a healthy portfolio in 2025. Read more….

Despite Abbott Laboratories’ underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish about the stock’s prospects.